Kopasz Anna Georgina
The potential of a newly developed transgenic mouse liver platform in the investigation of hepatocellular carcinoma and perspectives on PARP inhibitor-based therapy.
Doktori értekezés, Szegedi Tudományegyetem (2000-).
(2026)